Company Profile
Laboratorio Farmaceutico Erfo S.p.A. is a company specialized in the formulation, production and marketing of nutraceutical products. The company stands at the centre of an ecosystem of brands mainly developed through franchising, comprising over 250 retail locations in Europe, focused on nutrition and 360-degree wellness. The business is organized around 4 areas of activity:
- Diètnatural: franchise dedicated to the sale of nutraceutical products linked to weight loss and the ongoing support of professionals specialized in nutrition;
- Division Médicale: a range of nutraceutical products dedicated to specific therapeutic areas (gastroenterology, neurology and musculoskeletal disorders, orthopedics);
- BodySano: French brand dedicated to offering new nutritional coaching methods combined with dietary supplements and aesthetic treatments using innovative tools;
- Fit&Go: Italy's leading franchise network in the world of high-tech fitness and fast fitness, offering customized wellness and health programs.
- Diètnatural: franchise dedicated to the sale of nutraceutical products linked to weight loss and the ongoing support of professionals specialized in nutrition;
- Division Médicale: a range of nutraceutical products dedicated to specific therapeutic areas (gastroenterology, neurology and musculoskeletal disorders, orthopedics);
- BodySano: French brand dedicated to offering new nutritional coaching methods combined with dietary supplements and aesthetic treatments using innovative tools;
- Fit&Go: Italy's leading franchise network in the world of high-tech fitness and fast fitness, offering customized wellness and health programs.
Source: Cofisem - Last Update: 2026-06-08
Key Executives
| Chairman and Chief Executive Officer | |
| Head of Investor Relations |
Source: Cofisem - Last Update: 2026-06-08
Key Figures
| Millenium | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Net sales | 9,494,781 | 5,828,485 | 5,737,059 | 4,624,287 | 4,818,434 |
| Consumed purchases | 2,938,179 | 1,675,321 | 1,662,370 | 1,319,870 | 1,370,627 |
| Labour costs | 1,515,957 | 1,260,220 | 1,036,069 | 890,572 | 694,251 |
| Operating profit | 1,066,386 | 523,867 | 836,742 | 987,032 | 1,580,046 |
| Income tax | 305,448 | 173,449 | 224,830 | 232,433 | 389,859 |
| Net income | 736,972 | 352,820 | 590,330 | 716,072 | 1,165,976 |
| Net income (Group share) | 381,623 | 366,979 | 553,815 | 716,072 | 1,165,976 |
| Fiscal year end | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Length of fiscal year (month) | 12 | 12 | 12 | 12 | 12 |
| Currency & Unit | EUR - unit | EUR - unit | EUR - unit | EUR - unit | EUR - unit |
| Account Standards | Local GAAP | Local GAAP | Local GAAP | Local GAAP | Local GAAP |
Source: Cofisem - Last Update: 2026-06-08
Shareholder information
| Active Capital Investment | |
| Free float | |
| Treasury shares |
Source: Cofisem - Last Update: 2026-06-08
Address
Laboratorio Farmaceutico Erfo S.p.A.
Viale Geki Russo 9
IT-98049 Villafranca Tirrena
Italy
Phone number: +39 090 914 6125
https://www.erfo.it/investor-relations/#investor-relation
Source: Cofisem - Last Update: 2026-06-08
Contact
Daniele Travisano
Phone number: 090 914 6125
IR@ERFO.IT
Phone number: 090 914 6125
IR@ERFO.IT
Source: Laboratorio Farmaceutico Erfo S.p.A. - Last Update: 2026-06-08
Please contact MyQuestion.Italy@euronext.com for Company Profile support.